The medtech trade bodies on PIP: crisis is a result of criminal action, not inadequacy of regs
This article was originally published in Clinica
Executive Summary
The case of the fraudulent PIP breast implants and its repercussions do not have anything to do with shortfalls in the regulatory system but rather with the criminal actions of the implants' French manufacturer.